Work

VOYAGER: an open-label, randomised, phase 3 study of avapritinib vs regorafenib in patients with locally advanced metastatic or unresectable gastrointestinal stromal tumour

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz155.196

Authors: S. Bauer, S. George, Y. Kang, R. Jones, O. Mir, W. Tap, A. Doyle, N. Picazio, T. Zhou, M. Roche, M. Heinrich

Institutions: University of Duisburg-Essen, Dana-Farber Cancer Institute, Asan Medical Center, Institute of Cancer Research, Royal Marsden Hospital, Institut Gustave Roussy, Memorial Sloan Kettering Cancer Center, Blueprint Medicines (United States), Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2954097433

FWCI: 1.362

Cites:

Cited by: 7

Related to: 10